MIF-I's differential actions as an opiate antagonist
- 31 December 1979
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 11 (6) , 721-723
- https://doi.org/10.1016/0091-3057(79)90270-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Naloxone-induced suppression of food intake in normal and hypothalamic obese ratsPharmacology Biochemistry and Behavior, 1979
- Analgesia after peripheral administration of enkephalin and endorphin analoguesPharmacology Biochemistry and Behavior, 1979
- CNS effects of peripherally administered brain peptidesLife Sciences, 1979
- Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamideEuropean Journal of Pharmacology, 1979
- Activity of VIP, somatostatin and other peptides in the mouse vas deferens assayPharmacology Biochemistry and Behavior, 1978
- Enkephalin and a potent analog facilitate maze performance after intraperitoneal administration in ratsPharmacology Biochemistry and Behavior, 1976
- Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependenceLife Sciences, 1976
- DOPA Potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF)Life Sciences, 1971